focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSaga Regulatory News (SAGA)

Share Price Information for Saga (SAGA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 127.60
Bid: 125.00
Ask: 151.00
Change: 0.00 (0.00%)
Spread: 26.00 (20.80%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 127.60
SAGA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of secondary placing of shares in Saga plc

2 Dec 2015 07:00

RNS Number : 6562H
BofA Merrill Lynch
02 December 2015
 

Not for publication, distribution or release directly or indirectly, in whole or in part, in or into the United States, Australia, Canada, Japan or Republic of South Africa or in any other jurisdiction in which offers or sales would be prohibited by applicable law.

This announcement is not an offer to sell or a solicitation to buy securities in any jurisdiction, including the United States, Australia, Canada, Japan or Republic of South Africa. Neither this announcement nor anything contained herein shall form the basis of, or be relied upon in connection with, any offer or commitment whatsoever in any jurisdiction.

Result of secondary placing of shares in Saga plc

Acromas Bid Co Limited ("Acromas"), announces that it has sold an aggregate of 145 million ordinary shares of Saga plc ("Saga", or the "Company"), representing approximately 13 per cent. of the Company's existing issued ordinary share capital, at a price of 200 pence per share (the "Placing").

Following settlement of the Placing, which is expected to take place on 4 December 2015, Acromas will hold approximately 32 per cent. of the Company's issued share capital. Consistent with this, Acromas has agreed that if the Placing proceeds it will not, for a period of 60 days following the announcement of the Placing, offer, sell or otherwise transfer any shares from its remaining shareholding in Saga without the consent of BofA Merrill Lynch and J.P. Morgan Cazenove subject to customary exceptions.

Enquiries:

BofA Merrill Lynch +44 20 7174 4000

Matthew Blawat

Daniel Burton-Morgan

J.P. Morgan Cazenove +44 20 7742 4000

Laurence Hollingworth

Nicholas Hall

 

 

 

Notes:

Acromas is owned and controlled by funds managed or advised by Charterhouse Capital Partners, CVC Capital Partners and Permira Advisers LLP, together with employees of the Company's group and other investors.

 

The distribution of this announcement and the offer and sale of the Placing Shares in certain jurisdictions may be restricted by law. The Placing Shares may not be offered to the public in any jurisdiction in circumstances which would require the preparation or registration of any prospectus or offering document relating to the Placing Shares in such jurisdiction. No action has been taken by Acromas Bid Co Limited, Merrill Lynch International ("BofAML"), J.P. Morgan Securities plc (which conducts its UK investment banking business as J.P. Morgan Cazenove) ("JPMC") or any of their respective affiliates that would permit an offering of the Placing Shares or possession or distribution of this announcement or any other offering or publicity material relating to such securities in any jurisdiction where action for that purpose is required.

This announcement is not for publication, distribution or release, directly or indirectly, in or into the United States of America (including its territories and dependencies, any State of the United States and the District of Columbia), Australia, Canada, Japan or Republic of South Africa or any other jurisdiction where such an announcement would be unlawful. The distribution of this announcement may be restricted by law in certain jurisdictions and persons into whose possession this document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. Neither this document nor the information contained herein constitutes or forms part of an offer to sell or the solicitation of an offer to buy securities in the United States. There will be no public offer of any securities in the United States or in any other jurisdiction.

In member states of the European Economic Area ("EEA") which have implemented the Prospectus Directive (each, a "Relevant Member State"), this announcement and any offer if made subsequently is directed exclusively at persons who are 'qualified investors' within the meaning of the Prospectus Directive ("Qualified Investors"). For these purposes, the expression 'Prospectus Directive' means Directive 2003/71/EC (and amendments thereto, including the 2010 PD Amending Directive, to the extent implemented in a Relevant Member State), and includes any relevant implementing measure in the Relevant Member State and the expression '2010 PD Amending Directive' means Directive 2010/73/EU. In the United Kingdom this announcement is directed exclusively at Qualified Investors (i) who have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Order") or (ii) who fall within Article 49(2)(A) to (D) of the Order, and (iii) to whom it may otherwise lawfully be communicated.

This announcement is not an offer of securities or investments for sale nor a solicitation of an offer to buy securities or investments in any jurisdiction where such offer or solicitation would be unlawful. No action has been taken that would permit an offering of the securities or possession or distribution of this announcement in any jurisdiction where action for that purpose is required. Persons into whose possession this announcement comes are required to inform themselves about and to observe any such restrictions.

In connection with any offering, BofAML, JPMC and any of their respective affiliates acting as an investor for its own account may take up as a proprietary position any Placing Shares and in that capacity may retain, purchase or sell for their own account such Placing Shares. In addition they may enter into financing arrangements and swaps with investors in connection with which they may from time to time acquire, hold or dispose of Placing Shares. Neither BofAML nor JPMC intend to disclose the extent of any such investment or transactions otherwise than in accordance with any legal or regulatory obligation to do so.

BofAML, which is authorised and regulated in the United Kingdom by the Prudential Regulation Authority and regulated by the Financial Conduct Authority, is acting on behalf of Acromas and no one else in connection with any offering of the Placing Shares and will not be responsible to any other person for providing the protections afforded to any of their clients or for providing advice in relation to any offering of the Placing Shares. BofAML will not regard any other person as their client in relation to the offering of the Placing Shares.

JPMC, which is authorised and regulated in the United Kingdom by the Prudential Regulation Authority and regulated by the Financial Conduct Authority, is acting on behalf of Acromas and no one else in connection with any offering of the Placing Shares and will not be responsible to any other person for providing the protections afforded to any of their clients or for providing advice in relation to any offering of the Placing Shares. JPMC will not regard any other person as their client in relation to the offering of the Placing Shares.

This document includes statements that are, or may be deemed to be, forward-looking statements. These forward-looking statements may be identified by the use of forward-looking terminology, including the terms "intends", "expects", "will", or "may", or, in each case, their negative or other variations or comparable terminology, or by discussions of strategy, plans, objectives, goals, future events or intentions. These forward-looking statements include all matters that are not historical facts. Any forward-looking statements are subject to risks relating to future events and assumptions relating to Saga's business, in particular from changes in political conditions, economic conditions, evolving business strategy, or the retail industry. No assurances can be given that the forward-looking statements in this document will be realised. As a result, no undue reliance should be placed on these forward-looking statements as a prediction of actual results or otherwise.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEMMMGZFMMGKZZ
Date   Source Headline
10th Sep 20202:33 pmRNSResults of Conditional Placing
10th Sep 20208:00 amRNSChange of Nomination Committee Membership & Chair
10th Sep 20207:15 amRNSCapital Raise
10th Sep 20207:00 amRNSInterim Results
1st Sep 20207:13 amRNSStatement re equity raise and strategic investment
19th Aug 20204:07 pmRNSDirector/PDMR Shareholding
7th Aug 20204:13 pmRNSSale of Bennetts Motorcycling Services Limited
31st Jul 202011:34 amRNSHolding(s) in Company
10th Jul 20203:23 pmRNSHolding(s) in Company
25th Jun 20205:19 pmRNSDirector/PDMR Shareholding
22nd Jun 20205:06 pmRNSResult of AGM
22nd Jun 20207:00 amRNSAGM Trading Update
3rd Jun 20204:25 pmRNSCorrection: Director/PDMR Shareholding
2nd Jun 20203:58 pmRNSDirector/PDMR Shareholding
2nd Jun 20203:58 pmRNSDirector/PDMR Shareholding
2nd Jun 20203:56 pmRNSDirector/PDMR Shareholding
19th May 20207:00 amRNSNotice of 2020 Annual General Meeting
9th Apr 20204:26 pmRNSHolding(s) in Company
9th Apr 202012:07 pmRNSSecond Price Monitoring Extn
9th Apr 202012:02 pmRNSPrice Monitoring Extension
9th Apr 20207:00 amRNSAnnual Report and Accounts and Strategic Report
2nd Apr 20207:00 amRNSDirector Retirement/ Audit Committee Chair Change
2nd Apr 20207:00 amRNSUnaudited Trading Update (inc. impact of COVID-19)
1st Apr 202012:02 pmRNSHolding(s) in Company
30th Mar 20203:56 pmRNSHolding(s) in Company
18th Mar 20202:11 pmRNSHolding(s) in Company
13th Mar 20207:00 amRNSUpdate in relation to travel advice from the Gov't
5th Mar 20207:00 amRNSSale of introductory care agencies, Trading Update
27th Feb 20207:00 amRNSDirector/PDMR Shareholdings
20th Feb 20207:00 amRNSNotice of Results
20th Feb 20207:00 amRNSNotice of Results
17th Feb 20207:00 amRNSSale of Bennetts Motorcycling Services Limited
31st Jan 20202:18 pmRNSDirector/PDMR Shareholding
28th Jan 20207:00 amRNSTrading update
17th Jan 20203:19 pmRNSChange in Remuneration Committee Responsibilities
16th Jan 20204:20 pmRNSDirector/PDMR Shareholding
9th Jan 20204:26 pmRNSDirector/PDMR Shareholding
3rd Jan 20203:00 pmRNSHolding(s) in Company
18th Dec 20199:45 amRNSDirector/PDMR Shareholding - Replacement
16th Dec 20194:28 pmRNSDirector/PDMR Shareholding
11th Dec 20197:00 amRNSEuan Sutherland appointed as Saga Group CEO
2nd Dec 20195:51 pmRNSDirector/PDMR Shareholding
27th Nov 20197:00 amRNSDirector/PDMR Shareholding
19th Nov 20197:00 amRNSDirectorate and Management Change
15th Nov 20194:52 pmRNSDirector/PDMR Shareholding
4th Nov 20197:00 amRNSSite tour of Spirit of Discovery
17th Oct 20197:00 amRNSDirector/PDMR Shareholding
15th Oct 20193:51 pmRNSDirector/PDMR Shareholding
2nd Oct 20194:07 pmRNSHolding(s) in Company
2nd Oct 20199:44 amRNSSaga launches new savings products

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.